OmniAb/$OABI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About OmniAb
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
Ticker
$OABI
Sector
Primary listing
Employees
89
Headquarters
Website
OmniAb Metrics
BasicAdvanced
$294m
-
-$0.46
0.62
-
Price and volume
Market cap
$294m
Beta
0.62
52-week high
$2.79
52-week low
$1.30
Average daily volume
859k
Financial strength
Current ratio
4.801
Quick ratio
4.549
Long term debt to equity
5.989
Total debt to equity
7.489
Profitability
EBITDA (TTM)
-33.435
Gross margin (TTM)
98.91%
Net profit margin (TTM)
-187.59%
Operating margin (TTM)
-187.74%
Effective tax rate (TTM)
1.75%
Revenue per employee (TTM)
$330,000
Management effectiveness
Return on assets (TTM)
-11.32%
Return on equity (TTM)
-20.25%
Valuation
Price to revenue (TTM)
8.368
Price to book
1.12
Price to tangible book (TTM)
4.94
Price to free cash flow (TTM)
-9.307
Free cash flow yield (TTM)
-10.74%
Free cash flow per share (TTM)
-0.218
Growth
Revenue change (TTM)
8.21%
Earnings per share change (TTM)
-23.07%
3-year revenue growth (CAGR)
-24.17%
3-year earnings per share growth (CAGR)
22.49%
OmniAb News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs